Hostname: page-component-6766d58669-bkrcr Total loading time: 0 Render date: 2026-05-18T20:10:02.049Z Has data issue: false hasContentIssue false
  • English
  • Français

Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy

Published online by Cambridge University Press:  26 February 2007

I D Miziara ,
R Weber ,
B Cunha Araújo Filho  and
C Diógenes Pinheiro Neto
I D Miziara*
Affiliation:
Division of Clinical Otorhinolaryngology, Department of Otorhinolaryngology and Ophthalmology, Medical School, University of Sao Paulo, Brazil.
R Weber
Affiliation:
Division of Clinical Otorhinolaryngology, Department of Otorhinolaryngology and Ophthalmology, Medical School, University of Sao Paulo, Brazil.
B Cunha Araújo Filho
Affiliation:
Division of Clinical Otorhinolaryngology, Department of Otorhinolaryngology and Ophthalmology, Medical School, University of Sao Paulo, Brazil.
C Diógenes Pinheiro Neto
Affiliation:
Division of Clinical Otorhinolaryngology, Department of Otorhinolaryngology and Ophthalmology, Medical School, University of Sao Paulo, Brazil.
*
Address for correspondence: Dr Ivan Dieb Miziara, Rua Cristiano Viana 450/121, Sao Paulo, BrazilCEP 05411-000. E-mail: miz@uol.com.br
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess changes in the prevalence of otitis media, associated with the use of highly active antiretroviral therapy, in Brazilian human immunodeficiency virus (HIV) infected children.

Setting:

Division of otorhinolaryngology, Hospital das Clínicas, Sao Paulo University Medical School, Brazil.

Patients:

A cohort of 459 HIV-infected children aged below 13 years.

Main outcome measures:

The prevalence of otitis media and the serum cluster of differentiation four glycoprotein T lymphocyte count were compared for children receiving highly active antiretroviral therapy (with protease inhibitors) and those receiving standard antiretroviral therapy (without protease inhibitors).

Results:

Otitis media was present in 33.1 per cent of the children. Children aged from zero years to five years 11 months receiving highly active antiretroviral therapy had a higher prevalence of acute otitis media (p=0.02) and a lower prevalence of chronic otitis media (p=0.02). Children who were receiving highly active antiretroviral therapy had a mean serum cluster of differentiation four glycoprotein T lymphocyte count greater than that of those who were receiving standard antiretroviral therapy (p<0.001).

Conclusions:

The use of highly active antiretroviral therapy in Brazilian HIV-infected children was associated with a lower prevalence of chronic otitis media.

Keywords

Antiretroviral Therapy, Highly ActiveHIVOtitis MediaChild

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 121 , Issue 11 , November 2007 , pp. 1048 - 1054
Copyright
Copyright © JLO (1984) Limited 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1UNAIDS–Global HIV/AIDS 2004 Report http://www.unaids.org/EN/other/functionalities/search.asp [9 May 2005]Google Scholar
2Surveillance Health Secretary, Federal Health Department, Brazil. National Program of STD and AIDS (Brazil) AIDS cases (numbers and percentuals) in 13 years old or less individuals, categorized according sex and year of diagnostic, 1980–2004. AIDS and STD Epidemiologic Bulletin 2004;1:32Google Scholar
3Hoare, S. HIV infection in children – impact upon ENT doctors. Int J Pediatr Otorhinolaryngol 2003;67(suppl 1):S85–90CrossRefGoogle ScholarPubMed
4Gortmaker, SL, Hughes, M, Cervia, J, Brady, M, Johnson, GM, Seage, GR III et al. Effects of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Eng J Med 2001;345:1522–8CrossRefGoogle ScholarPubMed
5Miziara, ID, Valentini, M, Romano, FR, Miniti, A. Changing patterns of buccal manifestations in AIDS. Rev Laryngol Otol Rhinol 2002;123:231–4Google ScholarPubMed
6Shapiro, NL, Novelli, V. Otitis media in children with vertically-acquired HIV infection: the Great Ormond Street Hospital experience. Int J Pediatr Otorhinolaryngol 1998;45:69–75CrossRefGoogle ScholarPubMed
7Williams, MA. Head and neck findings in pediatric acquired immune deficiency syndrome. Laryngoscope 1987;97:713–16CrossRefGoogle ScholarPubMed
8Rinaldo, A, Brandwein, MS, Devaney, KO, Ferlito, A. AIDS-related otological lesions. Acta Otolaryngol 2003;123:672–4CrossRefGoogle ScholarPubMed
9Barnett, ED, Klein, JO, Pelton, SI, Lunginbuhl, IM. Otitis media in children born to human immunodeficiency virus infected mothers. Pediatr Infect Dis J 1992;11:360–4CrossRefGoogle ScholarPubMed
10Caldwell, MB, Oxtoby, MJ, Simonds, RJ, Lindegren, ML, Rogers, MF. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. CDC Morbidity Mortality Weekly Report 1994;43:1–10Google Scholar
11Marchisio, P, Principi, N, Sorella, S, Sala, E, Tornaghi, R. Etiology of acute otitis media in human immunodeficiency virus infected children. Pediatr Infect Dis J 1996;15:58–61CrossRefGoogle ScholarPubMed
12Roland, PS. Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J 2002;81(suppl 1):8–10Google ScholarPubMed
13Verhoeff, M, van der Veen, EL, Rovers, MM, Schilder, AG. Int J Pediatr Otorhinolaryngol 2006; 70:1–12CrossRefGoogle Scholar
14Bernaldez, PC, Morales, G, Hernandez, CM. Chronic suppurative otitis media in HIV-infected children: P140. Otolaryngol Head Neck Surg 2005;133(suppl 1):243–4CrossRefGoogle Scholar
15Bluestone, CD. Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment. Int J Pediatr Otorhinolaryngol 1998;42:207–23CrossRefGoogle ScholarPubMed
16Chen, AY, Ohlms, LA, Stewart, MG, Kline, MW. Otolaryngologic disease progression in children with human immunodeficiency virus infection. Arch Otolaryngol Head Neck Surg 1996;122:1360–3CrossRefGoogle ScholarPubMed
17Chandrasekhar, SS, Connelly, PE, Brambhatt, SS, Shah, CS, Kloser, PC, Baredes, S. Otologic and audiologic evaluation of human immunodeficiency virus-infected patients. Am J Otolaryngol 2000;21:1–9CrossRefGoogle ScholarPubMed
18Chaloryoo, S, Chotpitayasunondh, T, Chiengmai, PN. AIDS in ENT in children. Int J Pediatr Otorhinolaryngol 1998;44:103–7CrossRefGoogle ScholarPubMed
19Singh, A, Georgalas, C, Patel, N, Papesch, M. ENT presentations in children with HIV infection. Clin Otolaryngol 2003;28:240–3CrossRefGoogle ScholarPubMed
20Hadfield, PJ, Birchall, MA, Novelli, V, Bailey, CM. The ENT manifestations of HIV infection in children. Clin Otolaryngol Allied Sci 1996;21:30–6CrossRefGoogle ScholarPubMed
21Zuccotti, GV, D'Auria, E, Torcoletti, M, Lodi, F, Bernardo, L, Riva, E. Clinical and pro-host effects of cefaclor in prophylaxis of recurrent otitis media in HIV-infected children. J Int Med Res 2001;29:349–54CrossRefGoogle ScholarPubMed
22Makokha, EP, Ogolla, M, Orago, AS, Koech, DK, Mpoke, S, Esamai, F et al. CD4 T lymphocyte subsets and disease manifestation in children with and without HIV born to HIV-infected mothers. East Afr Med J 2003;80:95–100Google Scholar
23Gondim, LA, Zonta, RF, Fortkamp, E, Schmeling, RO. Otorhinolaryngological manifestations in children with human immunodeficiency virus infection. Int J Pediatr Otorhinolaryngol 2000;54:97–102CrossRefGoogle ScholarPubMed
24Smirnova, MG, Birchall, JP, Pearson, JP. Evidence of T-helper cell 2 cytokine regulation of chronic otitis media with effusion. Acta Otolaryngol 2005;125:1043–50CrossRefGoogle ScholarPubMed
25Skotnicka, B, Stasiak-Barmuta, A, Hassmann-Poznanska, E, Kasprzycka, E. Lymphocyte subpopulations in middle ear effusions: flow cytometry analysis. Otol Neurotol 2005;26:567–71CrossRefGoogle ScholarPubMed
26Granados, JMS, Amador, JTR, Miguel, SF, Tomé, MIG, Conejo, PR, Vivas, PF et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003;22:863–7CrossRefGoogle Scholar
27Kline, MW. Human immunodeficiency virus protease inhibitors. Pediatr Infect Dis J 2003;22:1085–8CrossRefGoogle ScholarPubMed
28Principi, N. AIDS and the pediatric ENT specialist. Int J Pediatr Otorhinolaryngol 1995;32(suppl):S7–12CrossRefGoogle ScholarPubMed